Metrics as of 10/15/2026, 08:41 AM (Berlin time), refresh in progress.
GSK Stock
GSK plc
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- United Kingdom
- CEO
- Luke Victor Miels
- Employees
- 66,841
- Market cap
- £74.6 B
- IPO
- 01/07/1988
- Web
- www.gsk.com
GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures…
GSK stock: price history
1D
-0.3%
1W
+6.4%
1M
-0.2%
6M
-13.1%
YTD
+2.1%
1Y
+14.0%
2Y
+24.5%
5Y
+31.7%
10Y
+9.0%
Next earnings date
Next earnings date
28/10/2026 (in 11 days)
Volatility around earnings
~42% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 13/10/26. Not a buy or sell signal.Beta
What does this mean?
Double top
BearishThe price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about GSK
Analyst assessment of GSK
0
STRONG BUY
1
BUY
1
HOLD
1
SELL
0
STRONG SELL
3
TOTAL · Buy
As of: 23/03/2021
GSK stock metrics
P/E
15.52
P/B
4.24
EV/EBITDA
8.4
RETURN ON EQUITY
2.5%
NET MARGIN
5.2%
DEBT/EQUITY
1.03
DIVIDEND YIELD
3.7%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
96.9%
FLOAT SHARES
3,882,382,300
AVG. DAILY VOLUME (30D)
6,954,171
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about GSK stock
What does GSK do?
GSK plc is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in United Kingdom.
The CEO is Luke Victor Miels, the company employs around 66,841 people.
The IPO was on 01/07/1988; the stock trades on LSE under the ticker GSK.L.
What do analysts say about GSK stock?
3 analysts rate the stock, the consensus is Buy (as of 23/03/2021).
This is an external assessment, not a statement by Market Jury.
When does GSK report next?
The next earnings date is 28/10/2026.
Around past earnings, price swings were roughly 42% stronger than usual.
Does GSK pay a dividend?
Yes. The last dividend was £17.00 per share, ex-date 13/08/2026, paid on 08/10/2026.
The dividend yield is 3.7% (as of 30/06/2026).
Which stocks are comparable to GSK?
Comparable stocks include GSK, Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Roche Holding, Amgen and Gilead Sciences.
How can I get GSK stock analyzed?
Clicking "Analyze stock" lets five strategies assess GSK against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.